Pune, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The global contraceptives market is set to gain traction from the increasing adoption of low-dose combined oral contraceptives (COCs). They include progestogen blended with 20-35 micrograms of ethinylestradiol. This information is given by Fortune Business Insights™ in a new report, titled, “Contraceptives Market Size, Share & COVID-19 Impact Analysis, By Product (Contraceptive Drugs and Contraceptive Devices), By Gender (Male & Female) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, Clinics, Public Channel & NGOs, and Others), and Regional Forecast, 2020-2027.” The report further states that the market size was USD 22.49 billion in 2019 and is projected to reach USD 30.15 billion by 2027, exhibiting a CAGR of 5.5% during the forecast period.
This Report Answers the Following Questions:
- What are the market drivers, hindrances, and opportunities?
- Which segment is set to lead the market in the forthcoming years?
- Which region is expected to remain in the dominant position in the near future?
- How will the key organizations generate more sales amid the COVID-19 pandemic?
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptives-market-100064
Drivers & Restraints-
Increasing Government Initiatives to Skyrocket Demand for Contraceptives
As the population is surging worldwide, the governments are taking persistent initiatives to conduct awareness campaigns for lowering the risks of unwanted pregnancies, sexual disorders, and abortion. The Government of India, for instance, committed to deliver family planning services by the end of 2020 to 48 million new users at the London Summit on Family Planning. Similarly, the U.S. government developed an infant and a maternal health initiative to promote the usage of contraceptives effectively. However, contraceptives may cause multiple side-effects, such as migraine, headaches, and nausea. This factor may hinder contraceptives market growth.
COVID-19 Impacting Market Negatively Owing to Declining Production & Supply
The U.N. Population Fund (UNFPA) mentioned that in the coming months, 7 million unintended pregnancies are set to occur. Also, approximately 47 million women belonging to low- and medium-income countries would be unable to use unique contraceptives owing to the emergence of the COVID-19 pandemic. Besides, a major decline in the supply and manufacturing of these products worldwide would affect growth negatively. We are delivering in-depth research reports to help you better understand the current scenario of the market.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptives-market-100064
Segment-
Contraceptive Drugs Segment to Dominate Fueled by Their High Efficiency
Based on product, the drugs ices segment is set to grow with highest CAGR in the near future on account of their high demand, as well as their increasing efficiency in monitoring women’s health.
Regional Analysis-
Rising Cases of Teenage Pregnancies to Boost Growth in Europe
In 2019, North America generated USD 9.71 billion in terms of revenue and would lead in the forthcoming years. This growth is attributable to the increasing cases of unwanted pregnancies in the region. Europe is set to exhibit a considerable growth owing to the rising prevalence of teen pregnancies. Asia Pacific, on the other hand, is likely to exhibit a significant CAGR backed by the increasing entrance of new companies in the region.
Quick Buy - Contraceptives Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100064
Competitive Landscape-
Key Companies Aim to Gain Fast Track Approvals for Intensifying Competition
The market is fragmented owing to the availability of a large number of contraceptives. Most of the companies are frequently conducting elaborate studies to come up with state-of-the-art products to meet the growing demand. Some of the others are trying to bag FDA approvals for their newly discovered products. Below are two recent industry developments:
- August 2020: The U.S. Food and Drug Administration (FDA) approved a non-hormonal vaginal gel named Phexxi. It was developed by the University of Illinois Chicago. It is a combination of potassium bitartrate, citric acid, and lactic acid.
- August 2020: As per a study conducted by medRvix, female sex hormones may prevent the transmission of COVID-19. Some birth control pills, such as combination pills and estrogen-only pills can help in reducing the severity and susceptibility of COVID-19. But, researchers don’t recommend self-medication owing to the risk of side-effects.
Fortune Business Insights™ lists out the names of all the renowned producers present in the market. They are as follows:
- Pfizer, Inc.
- Bayer AG
- Cooper Surgical, Inc.
- The Female Health Company
- Teva Pharmaceutical Industries Limited
- Merck & Co., Inc.
- Mayer Laboratories, Inc
- Church & Dwight, Co., Inc.
- Medisafe Distribution Inc.
- Other Players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contraceptives-market-100064
Table of Contents:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Recent Industry Developments Such as Mergers & Acquisitions
- Regulatory Scenario for Key Countries
- New Service/Product Launch
- Technological Developments
- Key Industry Trends
- Global Contraceptives Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Contraceptive Drugs
- Oral
- Injectable
- Patches
- Contraceptive Devices
- Male Contraceptive Devices
- Female Contraceptive Devices
- Contraceptive Drugs
- Market Analysis, Insights and Forecast – By Gender
- Male
- Female
- Market Analysis, Insights and Forecast – By End User
- Hospital Pharmacy
- Retail Pharmacy
- Online Channel
- Public Channel & NGOs
- Clinics
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/contraceptives-market-100064
Have a Look at Related Reports:
Contraceptive Pills Market Share & Industry Analysis, By Type (Combination Pills and Progestin-only Pills), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others) and Regional Forecast, 2019-2026
Hormonal Contraceptives Market Share & Industry Analysis, By Product (Pills, Injectable, Vaginal Rings, Intrauterine Devices, Implants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel, Public Channel & NGOs, and Others) and Regional Forecast, 2019-2026
Contraceptive Drugs Market Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025
Contraceptive Devices Market Share and Global Trend By Product Type (Male & Female Contraceptive Devices, Technology (Hormonal & Barrier Contraceptives), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO & Others) and Geography Forecast till 2025
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/contraceptives-market-9060